{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:03:15Z","timestamp":1771434195645,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kunming University of Science and Technology (KUST) Medical Joint Research Program-Young Scholars Project","award":["KUST-AN2023010Q"],"award-info":[{"award-number":["KUST-AN2023010Q"]}]},{"name":"Yunnan Provincial Science and Technology Plan Project","award":["202301BE070001-039"],"award-info":[{"award-number":["202301BE070001-039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12613-2","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:54:24Z","timestamp":1769104464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a risk nomogram model for predicting superficial fungal infections in patients with type 2 diabetes mellitus : a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"12613_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"regional Global","year":"2023","unstructured":"Global regional, national burden of diabetes. From 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402:203\u201334.","journal-title":"Lancet"},{"key":"12613_CR2","first-page":"e280323215026","volume":"17","author":"P Chandra","year":"2024","unstructured":"Chandra P, Sachan N, Saraswat N, Vyawahare NA. Detailed review of molecular pathways and mechanisms responsible for the development and aggravation of neuropathy and nephropathy in diabetes. Curr Mol Pharmacol. 2024;17:e280323215026.","journal-title":"Curr Mol Pharmacol"},{"key":"12613_CR3","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","volume":"401","author":"EW Gregg","year":"2023","unstructured":"Gregg EW, et al. Improving health outcomes of people with diabetes: target setting for the WHO global diabetes compact. Lancet. 2023;401:1302\u201312.","journal-title":"Lancet"},{"key":"12613_CR4","doi-asserted-by":"crossref","unstructured":"Dwivedi J et al. Tailored therapies for hereditary diabetes: unraveling the genetic underpinnings of MODY and neonatal diabetes. Curr Gene Ther (2025).","DOI":"10.2174\/0115665232381943250825055516"},{"key":"12613_CR5","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2025.5956","volume":"334","author":"RR Kalyani","year":"2025","unstructured":"Kalyani RR, Neumiller JJ, Maruthur NM, Wexler DJ. Diagnosis and treatment of type 2 diabetes in adults: A review. JAMA. 2025;334:984\u20131002.","journal-title":"JAMA"},{"key":"12613_CR6","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1016\/S2468-2667(24)00250-0","volume":"9","author":"Y Xu","year":"2024","unstructured":"Xu Y, et al. Diabetes in China part 1: epidemiology and risk factors. Lancet Public Health. 2024;9:e1089\u201397.","journal-title":"Lancet Public Health"},{"key":"12613_CR7","doi-asserted-by":"crossref","unstructured":"Nagaram S et al. Role of exosomal MiRNAs and epigenetic modifications in diabetic nephropathy: insights into novel diagnostic and therapeutic strategies. Curr Gene Ther. 2025.","DOI":"10.2174\/0115665232376803250815065514"},{"key":"12613_CR8","doi-asserted-by":"crossref","unstructured":"Ning Y, Wang J, Zhou X, Wang G, Zhang L. Identification of novel biomarkers of bacterial lipopolysaccharides in diabetic nephropathy via transcriptomics and Mendelian randomization. Curr Gene Ther. 2025.","DOI":"10.2174\/0115665232353811250527053550"},{"key":"12613_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2337\/diaclin.33.1.40","volume":"33","author":"M Duff","year":"2015","unstructured":"Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous manifestations of diabetes mellitus. Clin Diabetes. 2015;33:40\u20138.","journal-title":"Clin Diabetes"},{"key":"12613_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40257-017-0275-z","volume":"18","author":"AL Lima","year":"2017","unstructured":"Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous manifestations of diabetes mellitus: A review. Am J Clin Dermatol. 2017;18:541\u201353.","journal-title":"Am J Clin Dermatol"},{"key":"12613_CR11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00125-024-06102-x","volume":"67","author":"RIG Holt","year":"2024","unstructured":"Holt RIG, Cockram CS, Ma RCW, Luk AOY. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia. 2024;67:1168\u201380.","journal-title":"Diabetologia"},{"key":"12613_CR12","doi-asserted-by":"crossref","unstructured":"Trovato L, Calvo M, De Pasquale R, Scalia G, Oliveri S. Prevalence of onychomycosis in diabetic patients: a case-control study performed at university hospital policlinico in Catania. J Fungi (Basel). 2022;8.","DOI":"10.3390\/jof8090922"},{"key":"12613_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pld.2018.07.001","volume":"40","author":"B Feng","year":"2018","unstructured":"Feng B, Yang Z. Studies on diversity of higher fungi in Yunnan, Southwestern china: A review. Plant Divers. 2018;40:165\u201371.","journal-title":"Plant Divers"},{"key":"12613_CR14","doi-asserted-by":"crossref","unstructured":"Giuliani E et al. Conventional diagnostic approaches to dermatophytosis: insights from a three-year survey at a public dermatology Institute in Italy (2019\u20132021). Diagnostics (Basel) 2025;15.","DOI":"10.3390\/diagnostics15172245"},{"key":"12613_CR15","doi-asserted-by":"publisher","first-page":"103915","DOI":"10.1016\/j.resmic.2021.103915","volume":"173","author":"A Mendon\u00e7a","year":"2022","unstructured":"Mendon\u00e7a A, Santos H, Franco-Duarte R, Sampaio P. Fungal infections diagnosis - Past, present and future. Res Microbiol. 2022;173:103915.","journal-title":"Res Microbiol"},{"key":"12613_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","volume":"30","author":"W Fang","year":"2023","unstructured":"Fang W, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30:42.","journal-title":"J Biomed Sci"},{"key":"12613_CR17","doi-asserted-by":"crossref","unstructured":"Trovato L et al. Multiplex real-time PCR for skin fungal infections: the diagnostic reliability in a one-year non-interventional study. Med Mycol. 2023;61.","DOI":"10.1093\/mmy\/myad092"},{"key":"12613_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/myc.13577","volume":"66","author":"D Navarro-P\u00e9rez","year":"2023","unstructured":"Navarro-P\u00e9rez D, et al. Onychomycosis associated with diabetic foot syndrome: a systematic review. Mycoses. 2023;66:459\u201366.","journal-title":"Mycoses"},{"key":"12613_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40200-021-00797-0","volume":"20","author":"S Rasoulpoor","year":"2021","unstructured":"Rasoulpoor S, et al. Candida albicans skin infection in patients with type 2 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20:665\u201372.","journal-title":"J Diabetes Metab Disord"},{"key":"12613_CR20","doi-asserted-by":"crossref","unstructured":"Kreouzi M et al. Skin microbiota: mediator of interactions between metabolic disorders and cutaneous health and disease. Microorganisms. 2025;13.","DOI":"10.3390\/microorganisms13010161"},{"key":"12613_CR21","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1128\/JCM.02035-09","volume":"48","author":"G Chellan","year":"2010","unstructured":"Chellan G, et al. Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes. J Clin Microbiol. 2010;48:2097\u2013102.","journal-title":"J Clin Microbiol"},{"key":"12613_CR22","doi-asserted-by":"publisher","first-page":"e70082","DOI":"10.1111\/myc.70082","volume":"68","author":"S Plangsiri","year":"2025","unstructured":"Plangsiri S, Arenas R, Rattananukrom T. Zoonotic and anthropophilic trichophyton mentagrophytes complex infection in human: an update and narrative review. Mycoses. 2025;68:e70082.","journal-title":"Mycoses"},{"key":"12613_CR23","doi-asserted-by":"publisher","first-page":"110910","DOI":"10.1016\/j.intimp.2023.110910","volume":"124","author":"GL Aruna","year":"2023","unstructured":"Aruna GL. Development and diagnostic evaluation of indirect enzyme linked immunosorbent assay for epidermophyton floccosum infection in humans. Int Immunopharmacol. 2023;124:110910.","journal-title":"Int Immunopharmacol"},{"key":"12613_CR24","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2147\/IDR.S455485","volume":"17","author":"L Shi","year":"2024","unstructured":"Shi L, Li J, Liu W, Shi D. Coexistence of malassezia species and microsporum canis in the lesions of adult with Tinea capitis. Infect Drug Resist. 2024;17:2431\u20138.","journal-title":"Infect Drug Resist"},{"key":"12613_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/jdv.19644","volume":"38","author":"AK Gupta","year":"2024","unstructured":"Gupta AK, et al. A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management. J Eur Acad Dermatol Venereol. 2024;38:480\u201395.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"12613_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539\u201353.","journal-title":"Diabet Med"},{"key":"12613_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12874-016-0267-3","volume":"16","author":"M van Smeden","year":"2016","unstructured":"van Smeden M, et al. No rationale for 1 variable per 10 events criterion for binary logistic regression analysis. BMC Med Res Methodol. 2016;16:163.","journal-title":"BMC Med Res Methodol"},{"key":"12613_CR28","doi-asserted-by":"crossref","unstructured":"Yin M et al. Development a risk prediction nomogram for multidrug\u2009\u2013\u2009resistant bacterial and fungal infection in gastrointestinal fistula patients during the perioperative period. Front Cell Infect Microbiol. 2024;14.","DOI":"10.3389\/fcimb.2024.1502529"},{"key":"12613_CR29","doi-asserted-by":"crossref","unstructured":"Wang X, Dai X, He Y, Chu J, Wang Y. Establishment and validation of a predictive nomogram for central venous catheter-related thrombosis in cancer patients: a retrospective nested case-control study. Front Oncol. 2024;14.","DOI":"10.3389\/fonc.2024.1418273"},{"key":"12613_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2022.01.011","volume":"145","author":"GFN Berkelmans","year":"2022","unstructured":"Berkelmans GFN, et al. Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice. J Clin Epidemiol. 2022;145:70\u201380.","journal-title":"J Clin Epidemiol"},{"key":"12613_CR31","doi-asserted-by":"crossref","unstructured":"Gupta AK, Shemer A, Economopoulos V, Talukder M. Diabetic foot and fungal infections: etiology and management from a dermatologic perspective. J Fungi (Basel) 2024;10.","DOI":"10.3390\/jof10080577"},{"key":"12613_CR32","first-page":"442","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16:442\u20139.","journal-title":"Curr Diabetes Rev"},{"key":"12613_CR33","doi-asserted-by":"crossref","unstructured":"Yan S et al. Characterization of pathogenic microorganisms in diabetic foot infections and development of a risk prediction model. Sci Rep. 2025;15.","DOI":"10.1038\/s41598-025-07092-5"},{"key":"12613_CR34","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41598-025-87011-w","volume":"15","author":"P Suphatsathienkul","year":"2025","unstructured":"Suphatsathienkul P, et al. Tinea manuum: a 5 year retrospective study of demographic data, clinical characteristics, and treatment outcomes. Sci Rep. 2025;15:3380.","journal-title":"Sci Rep"},{"key":"12613_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11046-016-9986-6","volume":"181","author":"W Cai","year":"2016","unstructured":"Cai W, et al. Epidemiology of superficial fungal infections in Guangdong, Southern china: A retrospective study from 2004 to 2014. Mycopathologia. 2016;181:387\u201395.","journal-title":"Mycopathologia"},{"key":"12613_CR36","doi-asserted-by":"crossref","unstructured":"Gupta AK et al. Onychomycosis in diabetics: a common infection with potentially serious complications. Life (Basel). 2025;15.","DOI":"10.3390\/life15081285"},{"key":"12613_CR37","doi-asserted-by":"crossref","unstructured":"Xiong J, Lu H, Jiang Y. A Causal Relationship between Type 2 diabetes and candidiasis through two-sample mendelian randomization analysis. Microorganisms. 2024;12.","DOI":"10.3390\/microorganisms12101984"},{"key":"12613_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/myc.12900","volume":"62","author":"S Ota\u0161evi\u0107","year":"2019","unstructured":"Ota\u0161evi\u0107 S, et al. Species distribution and epidemiological characteristics of superficial fungal infections in southeastern Serbia. Mycoses. 2019;62:458\u201365.","journal-title":"Mycoses"},{"key":"12613_CR39","doi-asserted-by":"crossref","unstructured":"Navarro-P\u00e9rez D et al. Prevalence and risk factors predicting onychomycosis in patients with and without diabetes mellitus in spain: a cross-sectional study. J Fungi (Basel). 2024;10.","DOI":"10.3390\/jof10110790"},{"issue":"Suppl 2","key":"12613_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1439-0507.2007.01425.x","volume":"50","author":"M Eckhard","year":"2007","unstructured":"Eckhard M, Lengler A, Liersch J, Bretzel RG, Mayser P. Fungal foot infections in patients with diabetes mellitus\u2013results of two independent investigations. Mycoses. 2007;50(Suppl 2):14\u20139.","journal-title":"Mycoses"},{"key":"12613_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s13340-024-00741-6","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, Kim MJ, Lee IK, Hong CW, Jeon JH. Impact of hyperglycemia on immune cell function: a comprehensive review. Diabetol Int. 2024;15:745\u201360.","journal-title":"Diabetol Int"},{"key":"12613_CR42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4093\/dmj.2025.0508","volume":"49","author":"T Kim","year":"2025","unstructured":"Kim T, Choi SH. Diabetes mellitus and infectious diseases: current evidence and clinical implications. Diabetes Metab J. 2025;49:915\u201333.","journal-title":"Diabetes Metab J"},{"key":"12613_CR43","first-page":"e51210","volume":"15","author":"N Alhammadi","year":"2023","unstructured":"Alhammadi N, et al. Prevalence and factors associated with Tinea pedis among diabetic patients in Saudi arabia: A descriptive Cross-Sectional study. Cureus. 2023;15:e51210.","journal-title":"Cureus"},{"key":"12613_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/ijd.ijd_1001_22","volume":"68","author":"AI Mustafa","year":"2023","unstructured":"Mustafa AI, et al. Apolipoprotein E gene Polymorphism, serum Lipids, and risk of superficial fungal infections in Egyptian Patients - A preliminary Case-Controlled study. Indian J Dermatol. 2023;68:233.","journal-title":"Indian J Dermatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12613-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12613-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12613-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:07:23Z","timestamp":1771430843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12613-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12613"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12613-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complied with the Declaration of Helsinki and was approved by the Institutional Review Board of The Affiliated Anning First People\u2019s Hospital of Kunming University of Science and Technology (Ethics Approval No.2023-045-SCI-02). Written informed consent was obtained from all participants prior to their enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}